Director Gabai-Pinsky Veronique exercised 900 shares at a strike of $97.84 and sold $105,173 worth of shares (900 units at $116.86) (SEC Form 4)
4 - INTERPARFUMS INC (0000822663) (Issuer)
Live Feed
Delayed 3mAnalyst · Insider · SEC · Financials
Signed out · 3-min delay · Sign up for real-time
- SEC Form 424B3 filed by Kazia Therapeutics Limited
424B3 - KAZIA THERAPEUTICS LTD (0001075880) (Filer)
- Sow Good Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
8-K - Sow Good Inc. (0001490161) (Filer)
- SEC Form 25-NSE filed by D. Boral ARC Acquisition I Corp.
25-NSE - D. Boral ARC Acquisition I Corp. (0002065779) (Subject)
- Amendment: Avantor Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
8-K/A - Avantor, Inc. (0001722482) (Filer)
- Dynatrace Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
8-K - Dynatrace, Inc. (0001773383) (Filer)
- SEC Form AW filed by Trinity Biotech plc
AW - TRINITY BIOTECH PLC (0000888721) (Filer)
- SEC Form FWP filed by Toronto Dominion Bank
FWP - TORONTO DOMINION BANK (0000947263) (Subject)
- Director Gundlach Andrew bought $2,407,650 worth of shares (10,000 units at $240.76) (SEC Form 4)
4 - WELLTOWER INC. (0000766704) (Issuer)
- Forgent Power Solutions, Inc. to Report Fiscal Fourth Quarter and Full Year 2026 Results
Forgent Power Solutions, Inc. (NYSE:FPS), a leading designer and manufacturer of electrical distribution equipment used in data centers, the power grid and energy-intensive industrial facilities, will report financial results for its fiscal fourth quarter and full year ended June 30, 2026, before the market opens on September 15, 2026, and management will host a conference call at 11:00 a.m. ET to discuss the results. The live webcast and replay, earnings press release and presentation materials will be available at ir.forgentpower.com. About Forgent Power Solutions Forgent (NYSE:FPS) is a leading U.S. designer and manufacturer of electrical distribution equipment used in data centers,
- SEC Form 424B3 filed by Kazia Therapeutics Limited
424B3 - KAZIA THERAPEUTICS LTD (0001075880) (Filer)
- SEC Form 25-NSE filed by Bleichroeder Acquisition Corp. II
25-NSE - Bleichroeder Acquisition Corp. II (0002088295) (Subject)
- Director Kornfeld Steven closing all direct ownership in the company (SEC Form 4) to cover withholding tax
4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 6-K filed by Kazia Therapeutics Limited
6-K - KAZIA THERAPEUTICS LTD (0001075880) (Filer)
- SEC Form N-PX filed by Virtus Convertible & Income Fund
N-PX - Virtus Convertible & Income Fund (0001214935) (Filer)
- SEC Form SCHEDULE 13G filed by NFT Limited
SCHEDULE 13G - NFT Ltd (0001958713) (Subject)
- SEC Form 4 filed by Director Brun Scott C. to cover withholding tax
4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form N-CSRS filed by Cornerstone Total Return Fund Inc.
N-CSRS - CORNERSTONE TOTAL RETURN FUND INC (0000033934) (Filer)